[Topical intranasal cortisone therapy]

Area of Science:

• Pharmacology
• Allergology
• Pulmonology

Background:

• Recent advancements in corticosteroid research have yielded new topical intranasal formulations.
• These corticosteroids exhibit high target organ activity with minimal systemic or local side effects.
• Topical intranasal corticosteroid therapy is now a cornerstone for allergic rhinitis and beneficial for various nasal and bronchopulmonary diseases.

Purpose of the Study:

• To review the general aspects of topical intranasal corticosteroids, including pharmacology, pharmacokinetics, toxicology, side effects, and contraindications.
• To analyze currently available topical intranasal corticosteroid drugs used internationally and in Italy.
• To compare the efficacy of different topical intranasal glucocorticoids and other therapeutic options.

Main Methods:

• Literature review and analysis of personal clinical experience.
• Pharmacological and pharmacokinetic profiling of intranasal corticosteroids.
• Comparative efficacy analysis of various topical intranasal glucocorticoids.

Main Results:

• Newer corticosteroids demonstrate significant efficacy with an improved safety profile for long-term use.
• Topical intranasal corticosteroids are indispensable for allergic rhinitis and useful in chronic rhinitis, nasal polyposis, asthma, and COPD.
• Comparative analysis provides insights into the relative effectiveness of different agents.

Conclusions:

• Topical intranasal corticosteroids represent a safe and effective therapeutic option for a range of respiratory conditions.
• The development of these agents has significantly improved management strategies for allergic rhinitis and related diseases.
• Further comparative studies reinforce their role as a primary treatment modality.